Shell Asset Management CO Summit Therapeutics Inc. Transaction History

Shell Asset Management CO

  • $2.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$2.55 - $5.07 $8,417 - $16,736
-3,301 Reduced 3.48%
91,609 $379,000
Q4 2023

Feb 14, 2024
SELL
$1.67 - $2.83 $371,291 - $629,193
-222,330 Reduced 70.08%
94,910 $248,000
Q3 2023

Nov 08, 2023
SELL
$1.54 - $2.42 $8,466 - $13,305
-5,498 Reduced 1.7%
317,240 $593,000
Q2 2023

Jul 28, 2023
BUY
$1.32 - $2.81 $426,014 - $906,893
322,738 New
322,738 $810,000

Others Institutions Holding SMMT

# of Institutions
192
Shares Held
75.8M
Call Options Held
2.01M
Put Options Held
2.84M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.6B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email